259 related articles for article (PubMed ID: 21683698)
21. Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord.
Chechneva OV; Mayrhofer F; Daugherty DJ; Pleasure DE; Hong JS; Deng W
Neurobiol Dis; 2011 Oct; 44(1):63-72. PubMed ID: 21704706
[TBL] [Abstract][Full Text] [Related]
22. Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation.
Miller LG; Young JA; Ray SK; Wang G; Purohit S; Banik NL; Dasgupta S
Neurochem Res; 2017 Oct; 42(10):2755-2768. PubMed ID: 28474276
[TBL] [Abstract][Full Text] [Related]
23. Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia.
Lepka K; Volbracht K; Bill E; Schneider R; Rios N; Hildebrandt T; Ingwersen J; Prozorovski T; Lillig CH; van Horssen J; Steinman L; Hartung HP; Radi R; Holmgren A; Aktas O; Berndt C
Glia; 2017 Sep; 65(9):1521-1534. PubMed ID: 28618115
[TBL] [Abstract][Full Text] [Related]
24. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase.
Hao W; Luo Q; Menger MD; Fassbender K; Liu Y
Front Immunol; 2021; 12():792465. PubMed ID: 34975892
[TBL] [Abstract][Full Text] [Related]
25. Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
Thakker P; Marusic S; Stedman NL; Lee KL; McKew JC; Wood A; Goldman SJ; Leach MW; Collins M; Kuchroo VK; Wolf SF; Clark JD; Hassan-Zahraee M
J Immunol; 2011 Aug; 187(4):1986-97. PubMed ID: 21746963
[TBL] [Abstract][Full Text] [Related]
26. Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis.
Chevalier AC; Rosenberger TA
J Neurochem; 2017 Jun; 141(5):721-737. PubMed ID: 28369944
[TBL] [Abstract][Full Text] [Related]
27. Altered expression of oligodendrocyte and neuronal marker genes predicts the clinical onset of autoimmune encephalomyelitis and indicates the effectiveness of multiple sclerosis-directed therapeutics.
Evangelidou M; Karamita M; Vamvakas SS; Szymkowski DE; Probert L
J Immunol; 2014 May; 192(9):4122-33. PubMed ID: 24683189
[TBL] [Abstract][Full Text] [Related]
28. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia.
Bannerman P; Hahn A; Soulika A; Gallo V; Pleasure D
Glia; 2007 Jan; 55(1):57-64. PubMed ID: 17009237
[TBL] [Abstract][Full Text] [Related]
29. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
Mondal S; Pahan K
PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
[TBL] [Abstract][Full Text] [Related]
30. Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Makar TK; Gerzanich V; Nimmagadda VK; Jain R; Lam K; Mubariz F; Trisler D; Ivanova S; Woo SK; Kwon MS; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2015 Nov; 12():210. PubMed ID: 26581714
[TBL] [Abstract][Full Text] [Related]
31. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Li M; Li Y; Liu X; Gao X; Wang Y
J Neuroimmunol; 2012 Jun; 247(1-2):25-31. PubMed ID: 22516472
[TBL] [Abstract][Full Text] [Related]
32. Oligodendrocyte-Specific Deletion of
Rajendran R; Rajendran V; Giraldo-Velasquez M; Megalofonou FF; Gurski F; Stadelmann C; Karnati S; Berghoff M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502405
[TBL] [Abstract][Full Text] [Related]
33. Effects of an aqueous extract of North American ginseng on MOG(35-55)-induced EAE in mice.
Bowie LE; Roscoe WA; Lui EM; Smith R; Karlik SJ
Can J Physiol Pharmacol; 2012 Jul; 90(7):933-9. PubMed ID: 22720838
[TBL] [Abstract][Full Text] [Related]
34. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Colombo E; Di Dario M; Capitolo E; Chaabane L; Newcombe J; Martino G; Farina C
Ann Neurol; 2014 Sep; 76(3):325-37. PubMed ID: 25043204
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the production of peroxynitrite in inflammatory CNS demyelination.
Cross AH; Manning PT; Stern MK; Misko TP
J Neuroimmunol; 1997 Dec; 80(1-2):121-30. PubMed ID: 9413267
[TBL] [Abstract][Full Text] [Related]
36. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).
Musgrave T; Benson C; Wong G; Browne I; Tenorio G; Rauw G; Baker GB; Kerr BJ
Brain Behav Immun; 2011 Nov; 25(8):1677-88. PubMed ID: 21723939
[TBL] [Abstract][Full Text] [Related]
37. Diphenyleneiodonium protects preoligodendrocytes against endotoxin-activated microglial NADPH oxidase-generated peroxynitrite in a neonatal rat model of periventricular leukomalacia.
He YF; Chen HJ; Qian LH; He LF; Buzby JS
Brain Res; 2013 Jan; 1492():108-21. PubMed ID: 23174417
[TBL] [Abstract][Full Text] [Related]
38. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
39. Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosis.
Dupree JL; Polak PE; Hensley K; Pelligrino D; Feinstein DL
J Neurochem; 2015 Jul; 134(2):302-14. PubMed ID: 25846048
[TBL] [Abstract][Full Text] [Related]
40. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
